Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:23 AM UTC
| NCT Number | NCT06805305 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | PHASE2 |
| Target Enrollment | 180 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Diakonos Oncology Corporation |
| Last Updated on CT.gov | July 1, 2026 (Jul 1, 2026) |
As of August 28, 2026: Clinical trial NCT06805305 is currently recruiting participants. This phase2 study for glioblastoma is actively seeking new participants at 18 locations across the United States. The study is sponsored by Diakonos Oncology Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06805305 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06805305 was last updated Jul 1, 2026 (July 1, 2026). HelloStudys verifies this status automatically.